Cerity Partners
DNA icon

Cerity Partners’s Ginkgo Bioworks DNA Stock Holding History

Cerity Partners’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,520
Closed -$87.2K – 2557
2024
Q2 		$87.2K Sell
6,520
-109
-2% -$3.25K ﹤0.01% 2125
2024
Q1 		$308K Buy
6,629
+1,389
+27% +$71.9K ﹤0.01% 1854
2023
Q4 		$354K Buy
5,240
+261
+5% +$16K ﹤0.01% 1433
2023
Q3 		$360K Buy
4,979
+4,648
+1,404% +$372K ﹤0.01% 1087
2023
Q2 		$24.6K Sell
331
-49
-13% -$2.9K ﹤0.01% 1598
2023
Q1 		$20.2K Buy
380
+21
+6% +$1.33K ﹤0.01% 1824
2022
Q4 		$24.3K Buy
359
+35
+11% +$3.22K ﹤0.01% 1456
2022
Q3 		$40K Buy
+324
New +$38.6K ﹤0.01% 1141

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return